In Vitro Diagnostics (IVD) Market is Determined to Cross US$ 77 Billion By 2022

The U.S. is estimated to be the largest IVD market. This market is broadly segmented into product, technique, application, end user, and region. Reagents, instruments, and software & services are included in the product segment. The reagents segment accounted for the largest share due to the reliable, specific, and faster detection of chronic diseases and genetic disorders at early stages.

The size of the global in vitro diagnostics (IVD) market is expected to reach about US$ 77 billion by 2022, at a compound annual growth rate (CAGR) of more than 5% during 2016 and 2022.

A glimpse of the report structure is provided in the report description available on the website.
https://www.marketresearchengine.com/reportdetails/global-in-vitro-diagnostics-ivd-market

The key players in the IVD market are Affymetrix, Inc., AlereInc, Biomerieux, Danaher Corporation., Roche Diagnostics, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Abbott Laboratories, Bayer AG., Arkray, Inc., Sysmex Corporation, Johnson & Johnson Pvt. Ltd. and Siemens AG. A detailed competitive landscape of these companies is provided with company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

It is capturing a decent growth rate in the health and fitness awareness section, due to the rise of chronic and infectious diseases, major technological advances, and improved disposable income of customers. However, the market growth is hindered by stringent government rules, lack of sufficient budget, and inauspicious reimbursement policies for novel diagnostic tests.

The end users of IVD in the U.S. are hospital laboratories, clinical/independent laboratories, and others. The hospital laboratories segment, in 2014, accounted for the largest share of the U.S. IVD market. The growing number of laboratories, inpatient and outpatient flow in hospitals, commonness of chronic and infectious diseases are the key driving factors.

The global IVD market is segmentation into North America, Europe, Asia Pacific, Latin America, Middle East and Africa by region. Each region is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and the GCC countries. The U.S. IVD market is segmented into the South, Midwest, Northeast, and West regions. In 2014, the South region accounted for the largest share of the market followed by West. However, the highest growth is expected in the Midwest region due to increasing demand for technologically advanced diagnosis devices and growing spending capabilities of consumers on healthcare.

Request Free Sample Report: https://www.marketresearchengine.com/reportdetails/global-in-vitro-diagnostics-ivd-market

The deep-dive study on the IVD market will help customers with identifications of new market opportunities and targeted promotional plans. The report provides global market trends, with data from 2013, estimates for 2014 and 2015, and projections of CAGRs through 2022.

Table of Contents

1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Rising Incidence of Chronic Lifestyle Diseases
5.2.1.2 Increasing Adoption of Point-Of-Care Testing
5.2.1.3 Growing Awareness of Personalized Medicine
5.2.1.4 Growth in the Number of Private Diagnostic Centers
5.2.2 Market Restraints
5.2.2.1 Inadequate Reimbursement
5.2.2.2 Rising Healthcare Costs and Low Budgets
5.2.3 Market Opportunities
5.2.3.1 Introduction of A New Range of Condition-Specific Markers and Tests With Advances in Genomics and Proteomics
5.2.3.2 Emerging Economies With Increasing Investments
5.2.3.3 Growing Significance of Companion Diagnostics
5.2.4 Market Challenges
5.2.4.1 Stringent Regulatory Framework
5.2.4.2 Operational Barriers for the Use of Diagnostic Tests
6 Industry Trends
7 Global In Vitro Diagnostics Market, By Product & Service
8 Global In Vitro Diagnostics Market, By Technology
9 Global In Vitro Diagnostics Market, By Application
10 Global In Vitro Diagnostics Market, By End User
11 Global In Vitro Diagnostics Market, By Region
12 Competitive Landscape
13 Company Profiles
13.1 Introduction
13.2 ABBott Laboratories, Inc.
13.3 Becton, Dickinson and Company
13.4 Biomérieux SA
13.5 Bio-Rad Laboratories, Inc.
13.6 Danaher Corporation
13.7 Johnson & Johnson
13.8 Roche Diagnostics
13.9 Siemens AG
13.10 Sysmex Corporation
13.11 Thermo Fisher Scientific, Inc.
13.12 Ortho-Clinical Diagnostics, Inc.
13.13 Qiagen N.V.
13.14 Diasorin S.P.A.

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.